Nishizaki, T. (2018). IL-33 suppresses GSK-3β activation through an ST2-independent MyD88/TRAF6/RIP/PI3K/Akt pathway. Heliyon.
Stile di citazione ChicagoNishizaki, Tomoyuki. "IL-33 Suppresses GSK-3β Activation Through an ST2-independent MyD88/TRAF6/RIP/PI3K/Akt Pathway." Heliyon 2018.
Citazione MLANishizaki, Tomoyuki. "IL-33 Suppresses GSK-3β Activation Through an ST2-independent MyD88/TRAF6/RIP/PI3K/Akt Pathway." Heliyon 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.